Berkeley Advanced Biomaterials

Berkeley Advanced Biomaterials (BAB) is a licensed tissue bank founded in 1996, accredited by the American Association of Tissue Banks (AATB). The company manufactures allograft, synthetic, and bioactive biologic solutions for orthopedic and soft tissue surgical applications. BAB focuses on cost-effective, clinically relevant products designed for bone regeneration, reconstruction, and soft tissue repair. The company serves surgeons and healthcare providers across orthopedic, spine, sports medicine, and general surgery specialties. As a regulated biologics manufacturer, BAB operates under tissue banking standards and compliance frameworks required for allograft processing and distribution. The company's product portfolio includes allograft bone and cartilage products, synthetic bone substitutes, and bioactive scaffolds for surgical implantation. BAB emphasizes clinical relevance and cost-effectiveness, positioning products as alternatives to autograft and xenograft materials while maintaining rigorous quality and safety standards.